Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 1
2013 1
2015 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Results by year

Filters applied: . Clear all
Page 1
Recurrence morbidity of olfactory neuroblastoma.
Melder K, Mace JC, Choby G, Almeida JP, Champagne PO, Chan E, Ciporen J, Chaskes MB, Fernandez-Miranda J, Fung NK, Gardner P, Hwang P, Ji KSY, Kalyvas A, Kong KA, Patel C, Patel Z, Celda MP, Pinheiro-Neto CD, Snyderman C, Thorp BD, Van Gompel JJ, Zenonos G, Zwagerman NT, Sanusi O, Wang EW, Geltzeiler M. Melder K, et al. Among authors: fung nk. Int Forum Allergy Rhinol. 2024 Apr 3. doi: 10.1002/alr.23351. Online ahead of print. Int Forum Allergy Rhinol. 2024. PMID: 38567900
Phase I dose-escalation study of the novel antiandrogen BMS-641988 in patients with castration-resistant prostate cancer.
Rathkopf D, Liu G, Carducci MA, Eisenberger MA, Anand A, Morris MJ, Slovin SF, Sasaki Y, Takahashi S, Ozono S, Fung NK, Cheng S, Gan J, Gottardis M, Obermeier MT, Reddy J, Zhang S, Vakkalagadda BJ, Alland L, Wilding G, Scher HI; Prostate Cancer Clinical Trials Consortium. Rathkopf D, et al. Among authors: fung nk. Clin Cancer Res. 2011 Feb 15;17(4):880-7. doi: 10.1158/1078-0432.CCR-10-2955. Epub 2010 Dec 3. Clin Cancer Res. 2011. PMID: 21131556 Free PMC article. Clinical Trial.
Mitigation of Adverse Clinical Events of a Narrow Target Therapeutic Index Compound through Modified Release Formulation Design: An in Vitro, in Vivo, in Silico, and Clinical Pharmacokinetic Analysis.
Good DJ, Hartley R, Mathias N, Crison J, Tirucherai G, Timmins P, Hussain M, Haddadin R, Koo O, Nikfar F, Fung NK. Good DJ, et al. Among authors: fung nk. Mol Pharm. 2015 Dec 7;12(12):4434-44. doi: 10.1021/acs.molpharmaceut.5b00624. Epub 2015 Nov 4. Mol Pharm. 2015. PMID: 26536519 Clinical Trial.
It is more than just beds.
Fung NK, Cullen L. Fung NK, et al. BJPsych Bull. 2015 Feb;39(1):51. doi: 10.1192/pb.39.1.51. BJPsych Bull. 2015. PMID: 26191432 Free PMC article. No abstract available.